← Leaderboards
Robert W Wilmott
Children'S Hospital Med Ctr (Cincinnati)
$57,080
Attributed
$57,080
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$57,080 · 2
By mechanism
M01$57,080 · 2
Top collaborators
No co-investigators on record.
Most similar at Children'S Hospital Med Ctr (Cincinnati)
Same institution · by research overlap
- Scott W Powers$22,989,087
- Floyd R Sallee$10,187,976
- Stephen R Daniels$15,503,269
- James E. Heubi$41,505,537
- Kathleen A Burklow$461,907
Others in their field
Top investigators on “Aminoglycoside Antibiotics”
- Peter S Steyger · Oregon Health And Science University$12,656,168
- Dev Priya Arya · Nubad, Llc$12,482,676
- Richard Edward Lee · Arietis$11,744,710
- Hiroshi Nikaido · University Of California Berkeley$9,666,442
- John S Blanchard · Yeshiva University$7,780,703
- David W Raible · University Of Washington$7,780,568
Research focus
Aminoglycoside AntibioticsClinical ResearchCystic FibrosisDrug Screening /EvaluationHuman SubjectHuman Therapy EvaluationDosagePseudomonas AeruginosaRespiratory Airway ClearanceSerumInfant Human (0-1 Year)Inhalation Drug AdministrationBlood ChemistryChild (0-11)PharmacokineticsClinical Trial Phase IPreschool Child (1-5)
Grant awards (4)
SAFETY OF AEROSOLIZED TOBRAMYCIN IN YOUNG CHILDREN W/ CYSTIC FIBROSIS$28,540
M01 · FY2001 · RR
Lower airway deposition of inhaled tobramycin in children with CF$0
M01 · FY2001 · RR
SAFETY OF AEROSOLIZED TOBRAMYCIN IN YOUNG CHILDREN W/ CYSTIC FIBROSIS$28,540
M01 · FY2000 · RR
Lower airway deposition of inhaled tobramycin in children with CF$0
M01 · FY2000 · RR